Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Phase 1a/1b Clinical Trials to Evaluate the Safety and Preliminary Efficacy of GNTbm-38.

This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy of GNTbm-38 in adult patients with advanced solid tumors and R/R PTCL.

Participants needed: 70
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Great Novel Therapeutics Biotech & Medicals CorporationUpdated: Sep 25, 2026
Eligibility criteria

Female and/or male aged ≥ 18 to ≤ 75 years. [+24]

Underlying physical or psychological medical condition that, in the opinion of t... [+8]

Status: Recruiting

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

This is a phase II, open-label, non-randomized, single-arm, multicenter study to evaluate the efficacy, safety, and PK of chidamide in patients with R/R PTCL.

Participants needed: 33
Trial details
Phase: Phase 2Age: 20-75Biological sex: AllType: InterventionalSponsor: Great Novel Therapeutics Biotech & Medicals CorporationUpdated: Jul 7, 2026Locations: 6
Eligibility criteria

Histopathological diagnosis, made by the investigator, of the following PTCL sub... [+8]

Females who are pregnant or breastfeeding, or females of childbearing potential... [+16]